Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority study of polyethylene glycol solution with vs without electrolytes for chronic constipation in elderly institutionalised patients
2007-001676-36Phase 4Completed
- Sponsor
- Orion Corporation
- Start
- Oct 2007
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of macrogol in chronic constipation (2 arms), sponsored by Orion Corporation. Primary endpoints: Primary efficacy endpoint and Primary safety and tolerability endpoint. Started Oct 2007; status: completed.
02
Drugs
macrogol
03
Conditions
chronic constipation
Beyond the preview
Go deeper on 2007-001676-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001676-36.